Entegrion
Entegrion is a Durham, NC-based life sciences company that develops and sells the VCM viscoelastic coagulation monitoring platform for point-of-care blood coagulation assessment, serving hospitals, emergency medicine providers, and veterinary practices in Europe and CE-accepting regions.
- Company typePrivate
- Founded2002
- HeadquartersDurham, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Entegrion firmographics
Firmographics- Name
- Entegrion
- Legal name
- Entegrion, Inc.
- Website
- https://entegrion.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Entegrion is a Durham, NC-based life sciences company that develops and sells the VCM viscoelastic coagulation monitoring platform for point-of-care blood coagulation assessment, serving hospitals, emergency medicine providers, and veterinary practices in Europe and CE-accepting regions.
- Ownership category
- akta.pro rank
Entegrion industry classification
Industry- Product category
- Point-of-Care Coagulation Diagnostics
- NAICS
- Medical Laboratories (621511)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer) (HLAHAOAC)
- akta.pro secondary industry
- Hematology & Coagulation Laboratories (HLAFAMAC)
Keywords
Where Entegrion is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Entegrion business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- VCM Hardware and Consumables Sales: Sale of VCM viscoelastic coagulation monitoring instruments and associated testing cartridges to healthcare facilities. The company sells both veterinary (VCMVet) and human-use (VCM Cascade) products through direct sales and e-commerce channels for existing customers.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Entegrion product offering
Product offeringCore offering
Entegrion develops and manufactures the VCM (Viscoelastic Coagulation Monitor), a point-of-care system that provides rapid, real-time hemostasis assessment using a small amount of fresh whole blood without chemical accelerants or sample manipulation. The platform is commercialized in two variants: VCMVet for veterinary practices and VCM Cascade for human clinical use in Europe and CE Mark-accepting regions.
Product overview
Entegrion offers the VCM (Viscoelastic Coagulation Monitor) platform, a point of care system for blood coagulation monitoring. The core VCM technology has been developed into two distinct sub-brands: VCMVet for veterinary care applications and VCM Cascade for human clinical use. Both products provide rapid, real-time hemostasis assessment using fresh whole blood at the bedside with full automation and no chemical modifications required.
Differentiator
Problem solved
Functional benefit
Brands
- VCM™: Viscoelastic coagulation monitor for human use - a point of care system for blood coagulation monitoring
- VCMVet™
- VCM Cascade™
Products and services
- VCM (Viscoelastic Coagulation Monitor) Point of care system for blood coagulation monitoring that provides rapid, real-time hemostasis assessment using fresh whole blood at the bedside. The fully automated test uses no chemical accelerants and requires no sample manipulation. Targeted at hospitals, emergency departments, surgical centers, and military field environments.
- VCMVet Veterinary-specific version of the VCM platform providing rapid, real-time hemostasis assessment at patient side for animals. Designed as a true point of care solution with three-step operation using untreated whole blood samples.
- VCM Cascade Human clinical version of the VCM analyzer providing point of care coagulation monitoring for human patients. Uses 300 microliters of whole blood directly from syringe with three-step operation and results displayed on touch screen within minutes.
Quantifiable outcome
- 800 million PT/PTT coagulation tests requested worldwide in point of care testing annually, indicating significant market opportunity
Companies that use Entegrion
Customer profileSegments3 records
Ideal customer profiles3 records
Entegrion technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Entegrion partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Entegrion competitors and assessment
Company assessmentDirect peers
- Werfen: Werfen markets the ROTEM and Quantra viscoelastic testing systems, the other principal viscoelastic platform competing against TEG and directly comparable to Entegrion's VCM in trauma, surgery, and point-of-care coagulation assessment.
- Diagnostica Stago: Stago is a specialized coagulation diagnostics company offering both laboratory and point-of-care hemostasis testing solutions. Directly comparable to Entegrion's clinical coagulation monitoring focus with broader product depth.
- Haemonetics Corporation: Haemonetics owns the TEG (thromboelastography) platform, the long-standing market leader in viscoelastic hemostasis testing for trauma, cardiac surgery, and obstetrics. Direct head-to-head competitor to Entegrion's VCM with similar clinical use cases and customer base.
Emerging players
- ELITech Group: ELITech Group manufactures and distributes specialty coagulation and hemostasis reagents and instruments for clinical laboratories. Comparable to Entegrion in clinical coagulation focus but smaller and emerging relative to the major incumbents.
Broad incumbents
- Siemens Healthineers: Siemens Healthineers offers central laboratory and POC coagulation analyzers across hospital networks globally, with a broad diagnostics portfolio that competes with Entegrion in hemostasis testing workflows.
- Hologic: Hologic acquired HemoSonics and its Quantra QPlus viscoelastic testing system in 2021, making it a broad-incumbent competitor with a more recently developed viscoelastic platform aimed at surgical and perioperative settings.
- Abbott: Abbott operates a broad diagnostics portfolio including point-of-care coagulation cartridges (i-STAT) widely used in hospitals worldwide. Represents a broad-incumbent competitor whose coagulation offering overlaps with VCM's clinical use cases.
- IDEXX Laboratories: IDEXX is the dominant veterinary diagnostics company, with in-clinic chemistry, hematology, and coagulation offerings sold to the same veterinary practices Entegrion targets with VCMVet. Represents a broad-incumbent competitor in the veterinary channel.
- Roche Diagnostics: Roche Diagnostics supplies coagulation testing solutions as part of its broad in-vitro diagnostics franchise and is the dominant central laboratory hemostasis partner for many US and EU hospitals.
Others
- Zoetis: Zoetis is a global animal health company with diagnostics and reference laboratory offerings serving veterinary practices. Comparable to Entegrion's veterinary focus but positioned as an adjacent ecosystem participant rather than a direct viscoelastic competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Entegrion social profiles
Digital presenceEntegrion compliance and trust
Trust signalCompliance1 record
Entegrion financial estimates
Financial estimateRevenue estimate
Valuation estimate
Entegrion leadership team
Management profileNumber of profiles
Profiles7 records
Entegrion funding detail
Funding detailFunding overview
Funding rounds5 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Entegrion M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Entegrion
What does Entegrion do?
Entegrion develops and manufactures the VCM (Viscoelastic Coagulation Monitor), a point-of-care system that provides rapid, real-time hemostasis assessment using a small amount of fresh whole blood without chemical accelerants or sample manipulation. The platform is commercialized in two variants: VCMVet for veterinary practices and VCM Cascade for human clinical use in Europe and CE Mark-accepting regions.
Is Entegrion a public or private company?
Entegrion is a private company. It is classified as unknown and is currently operating.
When was Entegrion founded?
Entegrion was founded in 2002. It employs 11 to 50 people.
Where is Entegrion based?
Entegrion is headquartered in Durham, United States, in the North America region.
How does Entegrion make money?
One revenue line is on record: VCM Hardware and Consumables Sales.
Who are Entegrion's main competitors?
Direct peers on record are Werfen, Diagnostica Stago and Haemonetics Corporation. ELITech Group is listed as an emerging player. Broad incumbents are Siemens Healthineers, Hologic, Abbott, IDEXX Laboratories and Roche Diagnostics. Zoetis is listed as an others.
Does Entegrion have an API?
No public API is recorded for Entegrion.
What industry is Entegrion in?
Entegrion's product category is Point-of-Care Coagulation Diagnostics. Its primary akta.pro industry code is HLAHAOAC, Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer), with a secondary code of HLAFAMAC, Hematology & Coagulation Laboratories. Its NAICS code is 621511 and its SIC code is 3826.